re: Ann: Shareholder Newsletter - March Quart... There are a lot of bargins in the market so if we get a cash offer I think take it flip it into something else.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%